NeurologyLive® Friday 5 — May 29, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Practical Use of Vorasidenib: Patient Selection, Monitoring, and Real-World Considerations

In this latest episode, Katherine B. Peters, MD, PhD, shares practical insights on prescribing vorasidenib, including patient education, safety monitoring, and how clinicians can confidently integrate this targeted therapy into routine care.

2: Nursing's Role in Neurology Care

In a recent Q&A, nurses Jeffrey Hernandez, DNP, APRN, and Bonnie Blain, RN, discussed the unique role of nurses in neurology, from their perspective working with patients with multiple sclerosis.

3: Understanding OFF Time in Parkinson’s Disease

In this latest episode, Daniel Kremens, MD, JD, and Joseph Possenti, Jr. examined how OFF time is defined and experienced from both patient and clinician perspectives.

4: Tourette Syndrome Awareness Month: Perspectives From Joohi Jimenez-Shahed, MD

In our latest NeuroVoices Q&A, Joohi Jimenez-Shahed, MD, professor of neurology at Mount Sinai, commented on the evolving understanding of Tourette syndrome, persistent misconceptions, and emerging therapeutic approaches for tic disorders.

5: Biomarkers, Complement Inhibition, and the Future of CIDP Care

In a recent Q&A, Karen Lynch, MD, MRCPI, senior global medical director at Sanofi, discussed ongoing unmet needs in CIDP, diagnostic challenges, and emerging research efforts evaluating complement inhibition care approaches.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!